Company Filing History:
Years Active: 2006
Title: Martin Armstrong: Innovator in Genotyping Cytochrome Expression
Introduction
Martin Armstrong is a notable inventor based in Wickambreaux, GB. He has made significant contributions to the field of pharmacogenomics, particularly in understanding drug metabolism. His work focuses on identifying genetic variations that influence how individuals metabolize medications.
Latest Patents
Armstrong holds a patent for a method of identifying subjects with varying drug metabolizing phenotypes associated with cytochrome CYP3A5 expression. This patent, titled "Genotyping Cytochrome Expression," describes a method that involves screening genomic DNA for the presence or absence of polymorphic variants in a transcription regulatory region of the CYP3A5 gene. The patent also includes oligonucleotide molecules that facilitate this screening process. He has 1 patent to his name.
Career Highlights
Martin Armstrong is currently employed at Janssen Pharmaceutica, where he continues to advance research in pharmacogenomics. His work has implications for personalized medicine, allowing for tailored drug therapies based on individual genetic profiles.
Collaborations
Armstrong collaborates with Aimée Dymphne Catherine Paulussen, contributing to innovative research in the field.
Conclusion
Martin Armstrong's contributions to the field of pharmacogenomics through his patent on genotyping cytochrome expression highlight the importance of genetic factors in drug metabolism. His work at Janssen Pharmaceutica continues to pave the way for advancements in personalized medicine.